ARCHIVES

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 37 | October 9, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

DCT Board Approves New Screening Program, Natural Product Concpets

March 1, 1985

Patient Advocacy: Policy Should Prevent Employers From Using Genetic Test Results

April 11, 1997

NCI Advised To Seek Greater Local Contribution to Construction Projects; Other changes Asked

January 28, 1977

INSPIRE Enrollment Stopped; Thromboembolism Risk Cited

February 25, 2011

Cancer Control Planning Completed, Going Through Final Review Process

July 12, 1974